ANG Lifesciences India Limited (ANG.BO)
INR 26.31
(-2.01%)
INR 26.31
(-2.01%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 90.66 Million INR | -58.58% |
| 2022 | 244.59 Million INR | -66.27% |
| 2021 | 687.97 Million INR | 341.35% |
| 2020 | 139.73 Million INR | 21.7% |
| 2019 | 125.58 Million INR | -1.26% |
| 2018 | 117.21 Million INR | 52.07% |
| 2017 | 70.79 Million INR | 19.28% |
| 2016 | 62.71 Million INR | 45.38% |
| 2015 | 48.9 Million INR | 54.03% |
| 2014 | 31.61 Million INR | -35.94% |
| 2013 | 49.62 Million INR | 88.59% |
| 2012 | 26.54 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -17.09 Million INR | -123.48% |
| 2023 Q1 | 68.63 Million INR | 528.13% |
| 2023 Q2 | 18.81 Million INR | -72.59% |
| 2023 FY | - INR | -58.58% |
| 2023 Q4 | 33.57 Million INR | 275.71% |
| 2023 Q3 | -19.1 Million INR | -201.54% |
| 2022 Q1 | 121.01 Million INR | -4.55% |
| 2022 Q2 | 98.09 Million INR | -18.94% |
| 2022 Q3 | 29.94 Million INR | -69.47% |
| 2022 Q4 | -16.03 Million INR | -153.54% |
| 2022 FY | - INR | -66.27% |
| 2021 Q1 | 295.56 Million INR | 785.95% |
| 2021 FY | - INR | 341.35% |
| 2021 Q3 | 53.22 Million INR | -73.32% |
| 2021 Q4 | 126.78 Million INR | 138.21% |
| 2021 Q2 | 199.46 Million INR | -32.51% |
| 2020 Q1 | 44.52 Million INR | 33.3% |
| 2020 Q3 | 17.37 Million INR | -60.98% |
| 2020 Q2 | 44.52 Million INR | 0.0% |
| 2020 FY | - INR | 21.7% |
| 2020 Q4 | 33.36 Million INR | 92.02% |
| 2019 FY | - INR | -1.26% |
| 2019 Q3 | 33.4 Million INR | 13.66% |
| 2019 Q2 | 29.38 Million INR | 0.0% |
| 2019 Q4 | 33.4 Million INR | 0.0% |
| 2019 Q1 | 29.38 Million INR | -14.26% |
| 2018 Q2 | 24.5 Million INR | 0.0% |
| 2018 FY | - INR | 52.07% |
| 2018 Q4 | 34.27 Million INR | -0.49% |
| 2018 Q3 | 34.44 Million INR | 40.56% |
| 2018 Q1 | 24.5 Million INR | -51.84% |
| 2017 FY | - INR | 19.28% |
| 2017 Q1 | 13.04 Million INR | -61.21% |
| 2017 Q2 | 13.04 Million INR | 0.0% |
| 2017 Q3 | 22.24 Million INR | 70.47% |
| 2017 Q4 | 50.87 Million INR | 128.71% |
| 2016 FY | - INR | 45.38% |
| 2016 Q4 | 33.63 Million INR | 114.67% |
| 2016 Q1 | 15.73 Million INR | 0.0% |
| 2016 Q2 | 15.73 Million INR | 0.0% |
| 2016 Q3 | 15.66 Million INR | -0.4% |
| 2015 FY | - INR | 54.03% |
| 2014 FY | - INR | -35.94% |
| 2013 FY | - INR | 88.59% |
| 2012 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -14093.571% |
| Sastasundar Ventures Limited | -203.51 Million INR | 144.549% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -682.648% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -1.856% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -7.641% |
| Sunil Healthcare Limited | 93.07 Million INR | 2.597% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -448.868% |
| MedPlus Health Services Limited | 3.94 Billion INR | 97.699% |
| Zenith Healthcare Limited | 4.98 Million INR | -1717.602% |
| Patidar Buildcon Limited | -5.52 Million INR | 1740.644% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -3.516% |
| Roopa Industries Limited | 55.7 Million INR | -62.765% |
| Smruthi Organics Limited | 120.31 Million INR | 24.644% |
| Trident Lifeline Limited | 102.69 Million INR | 11.716% |
| Bacil Pharma Limited | -569.32 Thousand INR | 16024.612% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 173.54% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -471.027% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 160.02% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -233.402% |
| PANJON LTD. | 4.08 Million INR | -2117.217% |
| Tyche Industries Limited | 128.2 Million INR | 29.285% |
| Trimurthi Limited | -2.47 Million INR | 3757.924% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 575.866% |
| Anuh Pharma Limited | 878.5 Million INR | 89.68% |
| Crestchem Limited | 30.33 Million INR | -198.876% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 938.066% |
| Zenlabs Ethica Limited | 27.09 Million INR | -234.596% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 76.568% |
| Parmax Pharma Limited | 22.93 Million INR | -295.257% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 76.692% |
| Deccan Health Care Limited | 37.5 Million INR | -141.727% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 58.142% |
| Norris Medicines Limited | -1.78 Million INR | 5181.538% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 64.331% |
| Veerhealth Care Limited | 15.99 Million INR | -466.815% |
| Makers Laboratories Limited | 25.81 Million INR | -251.24% |
| Lactose (India) Limited | 201.22 Million INR | 54.944% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 194.272% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 46.848% |
| Mercury Laboratories Limited | 101.18 Million INR | 10.402% |
| Gennex Laboratories Limited | 219.35 Million INR | 58.669% |
| PRAVEG LIMITED | 321.43 Million INR | 71.795% |
| Denis Chem Lab Limited | 224.84 Million INR | 59.679% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 85.148% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 76.007% |
| Colinz Laboratories Limited | 5.42 Million INR | -1570.265% |
| Godavari Drugs Limited | 134.62 Million INR | 32.656% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 22430.542% |
| Zenotech Laboratories Limited | 172.64 Million INR | 47.486% |
| Panchsheel Organics Limited | 189.36 Million INR | 52.124% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 79.798% |
| Vivanza Biosciences Limited | 11.2 Million INR | -709.193% |
| Phaarmasia Limited | -1.58 Million INR | 5830.847% |
| Bharat Parenterals Limited | 265.74 Million INR | 65.883% |
| Medi-Caps Limited | 4.77 Million INR | -1800.272% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 3433.162% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 89.09% |
| BDH Industries Limited | 124.27 Million INR | 27.046% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 380.002% |
| Coral Laboratories Limited | 227.07 Million INR | 60.074% |
| Concord Drugs Limited | 40.52 Million INR | -123.746% |
| Beryl Drugs Limited | 26.63 Million INR | -240.336% |
| Evoq Remedies Limited | 6.18 Million INR | -1365.132% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -9.74% |
| Transchem Limited | 56.61 Million INR | -60.149% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -662.635% |
| Parnax Lab Limited | 243.59 Million INR | 62.782% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -102.352% |
| Kerala Ayurveda Limited | 70.78 Million INR | -28.077% |
| Cian Healthcare Limited | 122.56 Million INR | 26.031% |
| Trinity League India Limited | -26.25 Million INR | 445.34% |
| Syschem (India) Limited | 70.4 Million INR | -28.779% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 1157.529% |
| Natural Capsules Limited | 219.9 Million INR | 58.771% |
| Auro Laboratories Limited | 121.73 Million INR | 25.526% |